Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II
OBJECTIVES: I. Assess the response of patients with adrenocortical carcinoma treated with
suramin. II. Evaluate the qualitative and quantitative toxic effects of this therapy.
OUTLINE: Patients are described according to stage, performance status, prior radiotherapy,
prior surgery, and prior mitotane therapy. Patients receive suramin IV for 5 days in the
first week, then twice a week for 2 weeks, and then weekly for a total of 12 weeks.
Hydrocortisone is taken PO twice daily. Following a 12 week rest, patients receive a second
course; those with stable or responding disease continue treatment for a maximum of four
courses.
PROJECTED ACCRUAL: A maximum of 40 patients will be accrued at a rate of 6-7 per year.
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Response to suramin
From date of registration to progression or date of death from any cause, whichever came first, assessed up to four cycles
No
Louis E. Schroder, MD
Study Chair
Barrett Cancer Center
United States: Federal Government
CDR0000065324
NCT00002921
March 1997
January 2004
Name | Location |
---|---|
Baylor College of Medicine | Houston, Texas 77030 |
Arizona Cancer Center | Tucson, Arizona 85724 |
University of Michigan Comprehensive Cancer Center | Ann Arbor, Michigan 48109-0752 |
Jonsson Comprehensive Cancer Center, UCLA | Los Angeles, California 90095-1781 |
USC/Norris Comprehensive Cancer Center | Los Angeles, California 90033-0800 |
Chao Family Comprehensive Cancer Center | Orange, California 92868 |
University of Colorado Cancer Center | Denver, Colorado 80262 |
Albert B. Chandler Medical Center, University of Kentucky | Lexington, Kentucky 40536-0084 |
Barbara Ann Karmanos Cancer Institute | Detroit, Michigan 48201 |
University of Mississippi Medical Center | Jackson, Mississippi 39216-4505 |
Barrett Cancer Center, The University Hospital | Cincinnati, Ohio 45219 |
Cleveland Clinic Cancer Center | Cleveland, Ohio 44195 |
CCOP - Upstate Carolina | Spartanburg, South Carolina 29303 |
Simmons Cancer Center - Dallas | Dallas, Texas 75235-9154 |
University of California Davis Medical Center | Sacramento, California 95817 |
CCOP - Wichita | Wichita, Kansas 67214-3882 |
MBCCOP - LSU Medical Center | New Orleans, Louisiana 70112 |
University of Texas Health Science Center at San Antonio | San Antonio, Texas 78284-7811 |
CCOP - Greater Phoenix | Phoenix, Arizona 85006-2726 |
CCOP - Atlanta Regional | Atlanta, Georgia 30342-1701 |
CCOP - Kansas City | Kansas City, Missouri 64131 |
UCSF Cancer Center and Cancer Research Institute | San Francisco, California 94115-0128 |
CCOP - Christiana Care Health Services | Wilmington, Delaware 19899 |
CCOP - Mount Sinai Medical Center | Miami Beach, Florida 33140 |
CCOP - North Shore University Hospital | Manhasset, New York 11030 |
CCOP - Southeast Cancer Control Consortium | Winston-Salem, North Carolina 27104-4241 |
MBCCOP - Massey Cancer Center | Richmond, Virginia 23298-0037 |
Loyola University Medical Center | Maywood, Illinois 60153 |
Henry Ford Hospital | Detroit, Michigan 48202 |
Huntsman Cancer Institute | Salt Lake City, Utah 84112 |
MBCCOP - University of South Alabama | Mobile, Alabama 36688 |
Beckman Research Institute, City of Hope | Los Angeles, California 91010 |
CCOP - Bay Area Tumor Institute | Oakland, California 94609-3305 |
CCOP - Santa Rosa Memorial Hospital | Santa Rosa, California 95403 |
CCOP - Central Illinois | Springfield, Illinois 62526 |
Tulane University School of Medicine | New Orleans, Louisiana 70112 |
St. Louis University Health Sciences Center | Saint Louis, Missouri 63110-0250 |
CCOP - Montana Cancer Consortium | Billings, Montana 59101 |
CCOP - Columbus | Columbus, Ohio 43206 |
CCOP - Dayton | Kettering, Ohio 45429 |
CCOP - Columbia River Program | Portland, Oregon 97213 |
CCOP - Greenville | Greenville, South Carolina 29615 |
University of Texas Medical Branch | Galveston, Texas 77555-1329 |
Swedish Cancer Institute | Seattle, Washington 98104 |
CCOP - Scott and White Hospital | Temple, Texas 76508 |
Cancer Research Center of Hawaii | Honolulu, Hawaii 96813 |
University of Arkansas for Medical Sciences | Little Rock, Arkansas 72205 |
Dwight David Eisenhower Army Medical Center | Fort Gordon, Georgia 30905-5650 |
University of Kansas Medical Center | Kansas City, Kansas 66160-7353 |
Boston Medical Center | Boston, Massachusetts 02118 |
Providence Hospital - Southfield | Southfield, Michigan 48075-9975 |
Veterans Affairs Medical Center - Kansas City | Kansas City, Missouri 64128 |
CCOP - St. Louis-Cape Girardeau | Saint Louis, Missouri 63141 |
Herbert Irving Comprehensive Cancer Center | New York, New York 10032 |
Oklahoma Medical Research Foundation | Oklahoma City, Oklahoma 73104 |
Brooke Army Medical Center | Fort Sam Houston, Texas 78234-6200 |
Texas Tech University Health Science Center | Lubbock, Texas 79415 |
CCOP - Virginia Mason Research Center | Seattle, Washington 98101 |
CCOP - Northwest | Tacoma, Washington 98405-0986 |
CCOP - Grand Rapids Clinical Oncology Program | Grand Rapids, Michigan 49503 |
Oregon Cancer Center at Oregon Health Sciences University | Portland, Oregon 97201-3098 |
University of New Mexico Cancer Research & Treatment Center | Albuquerque, New Mexico 87131 |
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. | Syracuse, New York 13217 |
Eastern Virginia Medical School | Norfolk, Virginia 23507 |
Louisiana State University Hospital - Shreveport | Shreveport, Louisiana 71130-3932 |